Sponsor or institution
Clinical trials and research at Quell Therapeutics Limited
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Quell Therapeutics Limited that are recruiting, at sites in 3 countries (most in United Kingdom (2), Germany (1), Spain (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Using long-lived immune cells to calm an overactive immune system
This trial will try QEL-005, an autologous CD19-directed CAR-T regulatory cell therapy, to calm immune overactivity in adults with diffuse cutaneous systemic sclerosis or difficult-to-treat rheumatoid arthritis.
-
Investigating white blood cells to develop new therapies for autoimmune diseases
This study is trying to learn more about white blood cells from volunteers to help create new treatments for autoimmune diseases.
Quick answers
How many clinical trials run by Quell Therapeutics Limited are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United Kingdom (2 trials), Germany (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.